Today, the CEO & COB of Inovalon (INOV), Keith Dunleavy, bought shares of INOV for $1.84M.
This recent transaction increases Keith Dunleavy’s holding in the company by 42.31% to a total of $7.06 million. Following Keith Dunleavy’s last INOV Buy transaction on May 16, 2018, the stock climbed by 3.2%.
See today’s analyst top recommended stocks >>
Based on Inovalon’s latest earnings report for the quarter ending March 31, the company posted quarterly revenue of $145 million and GAAP net loss of $8.32 million. In comparison, last year the company earned revenue of $92.76 million and had a GAAP net loss of $16.27 million. Currently, Inovalon has an average volume of 341.9K.
Based on 3 analyst ratings, the analyst consensus is Moderate Sell with an average price target of $12.33, reflecting a -7.2% downside.
Company insider trades are published daily on the SEC (Securities and Exchange Commission). DailyInsider’s proprietary algorithm analyzes these trades and selects the most attractive stocks based on influential insider trades each day. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded on September 11, 2014 and is headquartered in Bowie, MD.
